Next Article in Journal
The Impacts of Anti-Inflammatory Agents on COVID-19 Cytokine Storm
Previous Article in Journal
Food Advertising to Children in New Zealand: A Critical Review of the Performance of a Self-Regulatory Complaints System Using a Public Health Law Framework
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Abstract

Vitamin D and COVID-19: A PubMed-Based Overview of Reviews †

1
Department of Public Health, AUSL-IRCCS of Reggio Emilia, Via Giovanni Amendola 2, 42122 Reggio Emilia, Italy
2
Cardiology Unit, University Hospital of Parma, 43121 Parma, Italy
3
CERFIT, Careggi University Hospital, 50134 Florence, Italy
*
Author to whom correspondence should be addressed.
Presented at the 3rd International Electronic Conference on Environmental Research and Public Health—Public Health Issues in the Context of the COVID-19 Pandemic, 11–25 January 2021; Available online: https://ecerph-3.sciforum.net/.
Med. Sci. Forum 2021, 4(1), 40; https://doi.org/10.3390/ECERPH-3-09051
Published: 11 January 2021

Abstract

:
In recent years, the role of vitamin D in the immune system has been explored. In light of the global burden of COVID-19, this literature overview aims to understand whether vitamin D can be a useful integrative option for COVID-19 prevention. A PubMed-based overview of reviews (date of search: 7 December 2020). After a database search, 305 articles were found, and 15 reviews were included in this study. From a mechanistic perspective, vitamin D may inactivate some viral compounds, reduce pro-inflammatory cytokines (NF-kB, IL-6, TNF), modulate ACE-2 and MMP-9 concentrations, and diminish the risk of endothelial dysfunction and bradykinin storm. In a meta-analysis, a positive association between vitamin D deficiency and COVID-19 severity was observed (OR = 1.64; 95% C.I.: [1.30; 2.09]), and other researchers suggested that this association may also involve an increased risk of infection. A preventive role was hypothesized even for diabetic, obese, or pediatric subjects. However, in most reviews, the evidence base was considered insufficient to draw definitive conclusions. In a broad meta-analysis, it was reported that administering 400–1000 IU/day of vitamin D for up to 12 months was significantly associated with some degree of protection against acute respiratory infections (OR = 0.70; 95% C.I.: [0.72; 0.93]). Some studies indicated that vitamin D serum concentrations of 20–30 ng/mL reduced the risk of acute respiratory infections, while others pointed out that higher levels (up to 40–60 ng/mL) may be preferable for this purpose. In conclusion, vitamin D supplementation may be useful for COVID-19, especially in individuals with low levels of this micronutrient. In fact, vitamin D deficiency is associated with worse disease severity and possibly with an increased risk of infection. Considering its high tolerability and low costs, further large clinical studies are advised to ascertain whether a standardized supplementation may be a valuable clinical strategy to apply on a large scale.

Author Contributions

All the authors have equally contributed in the development of this research. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data sharing not applicable.

Conflicts of Interest

No conflict of interest has to be declared by the authors.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Antonelli, M.; Donelli, D.; Firenzuoli, F. Vitamin D and COVID-19: A PubMed-Based Overview of Reviews. Med. Sci. Forum 2021, 4, 40. https://doi.org/10.3390/ECERPH-3-09051

AMA Style

Antonelli M, Donelli D, Firenzuoli F. Vitamin D and COVID-19: A PubMed-Based Overview of Reviews. Medical Sciences Forum. 2021; 4(1):40. https://doi.org/10.3390/ECERPH-3-09051

Chicago/Turabian Style

Antonelli, Michele, Davide Donelli, and Fabio Firenzuoli. 2021. "Vitamin D and COVID-19: A PubMed-Based Overview of Reviews" Medical Sciences Forum 4, no. 1: 40. https://doi.org/10.3390/ECERPH-3-09051

APA Style

Antonelli, M., Donelli, D., & Firenzuoli, F. (2021). Vitamin D and COVID-19: A PubMed-Based Overview of Reviews. Medical Sciences Forum, 4(1), 40. https://doi.org/10.3390/ECERPH-3-09051

Article Metrics

Back to TopTop